Kerstin Lindblad-Toh Selected Research

Dog Diseases (Disease, Canine)

3/2011	A novel unstable duplication upstream of HAS2 predisposes to a breed-defining skin phenotype and a periodic fever syndrome in Chinese Shar-Pei dogs.
1/2011	A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kerstin Lindblad-Toh Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 01/2007
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 03/2010
4	Hemangiosarcoma (Angiosarcoma) 01/2021 - 09/2014
3	Melanoma (Melanoma, Malignant) 01/2019 - 08/2008
3	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 01/2009
3	Atopic Dermatitis (Atopic Eczema) 01/2016 - 01/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2018
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 03/2011
2	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Hypothyroidism 04/2020 - 01/2015
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2020 - 10/2017
2	Mental Disorders (Mental Disorder) 01/2020 - 10/2017
2	Rheumatic Diseases (Rheumatism) 01/2018 - 03/2010
2	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 12/2013
2	Neuroblastoma 10/2017 - 03/2014
2	Hypersensitivity (Allergy) 01/2016 - 01/2012
2	Arteritis 06/2015 - 03/2010
2	Meningitis 06/2015 - 03/2010
2	Diabetes Mellitus 01/2015 - 01/2014
2	Infections 01/2015 - 12/2014
2	Atrophy 08/2014 - 01/2011
2	IgA Deficiency 08/2014 - 06/2013
2	Metrorrhagia (Spotting) 01/2014 - 05/2010
2	Dog Diseases (Disease, Canine) 03/2011 - 01/2011
1	Vasculitis (Vasculitides) 01/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022
1	Microscopic Polyangiitis 01/2022
1	Lupus Nephritis 01/2021
1	Ankylosing Spondylitis 01/2021
1	Addison Disease (Addison's Disease) 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Residual Neoplasm 01/2017
1	Body Weight (Weight, Body) 10/2016
1	Obesity 10/2016
1	Spinal Cord Diseases 05/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2015
1	Muscular Dystrophies (Muscular Dystrophy) 11/2015
1	Mastocytosis 11/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2015
1	Primary Immunodeficiency Diseases 01/2015
1	Human Influenza (Influenza) 12/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2014
1	Genomic Instability 09/2014

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
4	Biological ProductsIBA 01/2021 - 01/2007
3	AutoantibodiesIBA 01/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2014
3	Transcription Factors (Transcription Factor)IBA 10/2017 - 01/2014
3	Immunoglobulin A (IgA)IBA 01/2015 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2009
2	Immunoglobulin E (IgE)IBA 01/2016 - 01/2012
2	AntibodiesIBA 01/2016 - 01/2012
2	Antinuclear AntibodiesIBA 06/2015 - 03/2010
2	SteroidsIBA 06/2015 - 03/2010
2	ElementsIBA 12/2013 - 08/2012
2	Retinaldehyde (Retinal)IBA 01/2011 - 09/2008
1	Complement System Proteins (Complement)IBA 11/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	LipidsIBA 01/2022
1	InterferonsIBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 11/2020
1	Hormones (Hormone)IBA 11/2020
1	Interferon-alpha (Interferon Alfa)IBA 04/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Interleukin-22 (IL-22)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 01/2018
1	Histone MethyltransferasesIBA 01/2018
1	AutoantigensIBA 01/2018
1	CytokinesIBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 10/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2017
1	EndorphinsIBA 10/2016
1	Melanocyte-Stimulating Hormones (MSH)IBA 10/2016
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2016
1	AllergensIBA 01/2016
1	Jagged-1 ProteinIBA 11/2015
1	DystrophinIBA 11/2015
1	1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimideIBA 11/2015
1	Codon (Codons)IBA 11/2015
1	TRPC6 Cation ChannelIBA 02/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	P-2 (P 2)IBA 01/2015
1	Amylases FDA Link 10/2014
1	EnzymesIBA 10/2014
1	IntegrinsIBA 04/2014

Therapy/Procedure

4	Therapeutics 01/2017 - 06/2010